RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Q: What does CUSIP 75382E109 represent in this 13F holders report?

CUSIP 75382E109 is the security identifier for RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share in Q1 2020?

37 institutional investors reported RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 75382E109

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock $0.0001 par value per share
Shares outstanding: 27,725,634
Total 13F shares: 11,682,494
Share change: +2,544,114
Total reported value: $247,909,000
Price per share: $21.27
Number of holders: 37
Value change: +$53,863,363
Number of buys: 27
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP 75382E109?
CUSIP 75382E109 identifies RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 75382E109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT) as of Q1 2020

As of 31 Mar 2020, RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,682,494 shares. The largest 10 holders included Svennilson Peter, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., BlackRock Inc., VANGUARD GROUP INC, LUMINUS MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.